Đang chuẩn bị liên kết để tải về tài liệu:
Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: A single center study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Pulmonary exacerbations (PEx) are a major driver of morbidity and mortality in cystic fibrosis and reducing their frequency by extending the time between them is an important therapeutic goal. Although treatment decisions for exacerbations are often made based on dynamic changes in lung function, it is not clear if these changes truly impact future exacerbation risk. |

TÀI LIỆU LIÊN QUAN

How long do the Hong Kong Chinese expect their URTI to last? – Effects on antibiotic use

Duration of antibiotic treatment and risk of recurrence after surgical management of orthopaedic device infections: A multicenter case-control study

Báo cáo y học: "Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial"

Báo cáo y học: "Procalcitonin to guide duration of antibiotic therapy in intensive care patients: some research questions"

Non-inferior comparative study comparing one or two day antimicrobial prophylaxis after clean orthopaedic surgery (NOCOTA study): A study protocol for a cluster pseudo-randomized controlled trial comparing duration of antibiotic prophylaxis

Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: A single center study
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.